Dermatitis, Atopic
Conditions
Keywords
Dry skin / Xerosis
Brief summary
This is an observational study which means only data are collected from participants about their experience and symptoms, who received their usual treatment without any intervention from the study sponsor. Atopic dermatitis, also known as eczema, is a long-lasting skin disease that causes redness, swelling, dryness, cracking, and intense itching. Xerosis is the scientific wording to describe dry skin. This condition is caused by a weakened skin barrier that does not hold moisture well. DIPROBASE® advanced eczema cream is already available for use in the UK. It moisturizes and protects the skin. This study is being done to understand how people use DIPROBASE® Advanced Eczema Cream and how consistently they adhere to its recommended use in their daily routines. In this study, participants will be asked to fill in an online questionnaire about their eczema symptoms and experience with DIPROBASE® Advanced Eczema Cream. No treatment advice will be given as a part of this study. The main purpose of this study is to gather feedback from people in the UK who have used DIPROBASE® Advanced Eczema Cream to treat their eczema or their dry skin condition. To do this, researchers will collect the following information from participants: * intensity of eczema symptoms * whether the cream provides a cooling or soothing effect * whether the cream helps to ease the symptoms like itchiness, pain, or dryness It is planned to identify and collect user data from November 2024 to January 2025. Participants will be recruited through a consumer database available with an external partner or via social media. In this study, only data are collected. No visits or tests are required as part of this study.
Interventions
DEVICEMINERAL OIL + PETROLATUM (DIPROBASE® Advanced Eczema Cream, BAY987534, UI 1613882)
Product experience is assessed based on the answers provided by participants on the questions provided to them using an online questionnaire.
Sponsors
Bayer
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Participants: * Biological sex: M/F. * Age: \> or equal to 18 years of age. * Mothers, fathers, grandparents, and other caregivers aged 18 years of age and above, who will report data on themselves, their children from 2 to 12 years of age or their infants under 2 years of age. * Able to read and understand the language of the online questionnaire. * Have used the product within the previous three (3) months. * Agree that the data collected can be used for research, marketing and regulatory purposes.
Exclusion criteria
* Due to the real-world nature of the study, there are no
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Overall intensity of the symptoms | Retrospective analysis over three months | Subjects will be asked to complete an online questionnaire assessing the overall intensity of their symptoms over the past three months, using a 4-point scale (0-no symptoms to 4-severe symptoms). |
| Coolness or soothing effect | Retrospective analysis over three months | Subjects will be asked to complete an online questionnaire assessing their experience with the product over the past three months, using a 7-point scale (0-strongly disagree to 7-strongly agree). |
| Symptoms relief (skin irritation, pain, dryness) | Retrospective analysis over three months | Subjects will be asked to complete an online questionnaire assessing their experience with the product over the past three months, using a 7-point scale (0-strongly disagree to 7-strongly agree). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Descriptive summary of product usage: frequency, reasons, and ease of use | Retrospective analysis over three months | Subjects will be asked to complete an online questionnaire assessing various points on product utilization and product characteristics, i.e. the frequency with which they apply the product (once, twice, more than twice), the reasons for its use, whether they sought medical advice prior to commencing use, the number of consecutive days they used it, and their assessment of the ease of application (very easy, easy, neutral, difficult, very difficult). |
Countries
United Kingdom
Outcome results
None listed